Concepedia

Author

Huyen Cao

California Health and Human Services Agency

Also Known As

Anu Osinusi, Deborah Wentworth, HUYEN CAO, Huyen Cao, Huyen Hao Cao, Kássia Pereira, Marita Stevens

95

Publications

9.5K

Citations

34

H-Index

57

Concepts

All Affiliations

California Health and Human Services AgencyJoint Clinical Research CentreUniversity of California, San FranciscoGilead Sciences (United States)California Department of Public Health
HC

About

Huyen Cao is an author at California Health and Human Services Agency specializing in medicine, immunology, and hiv.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

21

1.4K

2

Cell Biology

3

3

102

3

Public Health

2

2

68

4

Allergy

2

2

45

5

Epidemiology

2

2

68

Huyen Cao

×

56

Publications

9K

Citations

31

H-Index

YearCitations

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Jonathan Grein, Norio Ohmagari, Daniel D. Shin,

New England Journal of Medicine

2020

2.9K

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman, David Chien Lye, David S.C. Hui,

New England Journal of Medicine

2020

1.4K

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

Christoph D. Spinner, Robert Gottlieb, Gerard J. Criner,

JAMA

2020

1.3K

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Paul E. Sax, David A. Wohl, Michael T. Yin,

The Lancet

2015

593

Depletion of Regulatory T Cells in HIV Infection Is Associated with Immune Activation

Mark P. Eggena, Banson Barugahare, Norman G. Jones,

The Journal of Immunology

2005

363

Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects

Rita Humeniuk, Anita Mathias, Huyen Cao,

Clinical and Translational Science

2020

261

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy

Anthony Mills, Gordon Crofoot, Cheryl McDonald,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2015

139

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson,

The Lancet Respiratory Medicine

2022

127

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

Iván O. Rosas, George Diaz, Robert Gottlieb,

Intensive Care Medicine

2021

124

High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort

Damalie Nakanjako, Isaac Ssewanyana, Harriet Mayanja‐Kizza,

BMC Infectious Diseases

2011

116

Page 1